Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NYU Langone Health Launches Parekh Center for Interdisciplinary Neurology to Accelerate Scientific Discovery
NYU Langone Health announced today the launch of the Parekh Center for Interdisciplinary Neurology, made possible […]
DeepSight ™ Technology Announces $25M Series A Funding Round
DeepSight ™ Technology has announced a $25 million Series A led by Deerfield Management Company, a healthcare investment […]
Salipro Biotech Enters into a Collaboration and License Agreement with AbCellera for access to the Salipro® Platform for Antibody Discovery Against GPCRs, Ion Channels, and Transporters
Swedish biotech company Salipro Biotech AB today announced that it has entered into a collaboration […]
Medtronic Hugo™ Robotic-Assisted Surgery System Receives European CE Mark Approval
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité […]
Blood Donation to be Made More Inclusive
People who want to donate blood, particularly Black African donors, will be able to do […]
AZD7442 Reduced Risk of Developing Severe COVID-19 or Death in TACKLE Phase III Outpatient Treatment Trial
Positive high-level results from the TACKLE Phase III COVID-19 treatment trial showed AstraZeneca‘s AZD7442, a […]
Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease
Fujitsu Limited today announced that it has started joint clinical research with the University of […]
NHS Mental Health Job Coaches Help Thousands Find Work
Thousands of people with mental health problems have been supported into employment during the pandemic, […]
Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced a non-exclusive clinical collaboration agreement […]
Moderna to Build State-of-the-Art mRNA Facility in Africa to Manufacture up to 500 Million Doses Per Year
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more